132 related articles for article (PubMed ID: 16465783)
1. [Immunologic response to (pre)neoplastic cervical lesions associated with human papillomavirus].
Delvenne P
Bull Mem Acad R Med Belg; 2005; 160(5-6):287-93. PubMed ID: 16465783
[TBL] [Abstract][Full Text] [Related]
2. [The biology of papillomavirus infections. III. Immune response].
Greslin I; Mougin C; Seilles E
Ann Biol Clin (Paris); 1998; 56(3):267-76. PubMed ID: 9754259
[TBL] [Abstract][Full Text] [Related]
3. Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.
Sheu BC; Chang WC; Lin HH; Chow SN; Huang SC
J Obstet Gynaecol Res; 2007 Apr; 33(2):103-13. PubMed ID: 17441881
[TBL] [Abstract][Full Text] [Related]
4. HPV modulation of host immune responses.
Feller L; Wood NH; Khammissa RA; Chikte UM; Meyerov R; Lemmer J
SADJ; 2010 Jul; 65(6):266-8. PubMed ID: 20879650
[TBL] [Abstract][Full Text] [Related]
5. HPV and cervical cancer: updates on an established relationship.
Subramanya D; Grivas PD
Postgrad Med; 2008 Nov; 120(4):7-13. PubMed ID: 19020360
[TBL] [Abstract][Full Text] [Related]
6. Immune evasion in human papillomavirus-associated cervical cancer.
Tindle RW
Nat Rev Cancer; 2002 Jan; 2(1):59-65. PubMed ID: 11902586
[TBL] [Abstract][Full Text] [Related]
7. Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.
Vinokurova S; Wentzensen N; Kraus I; Klaes R; Driesch C; Melsheimer P; Kisseljov F; Dürst M; Schneider A; von Knebel Doeberitz M
Cancer Res; 2008 Jan; 68(1):307-13. PubMed ID: 18172324
[TBL] [Abstract][Full Text] [Related]
8. HPV: from infection to cancer.
Stanley MA; Pett MR; Coleman N
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1456-60. PubMed ID: 18031245
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus: often harmless but in some cases carcinogenic.
Prescrire Int; 2007 Jun; 16(89):115-9. PubMed ID: 17585425
[TBL] [Abstract][Full Text] [Related]
10. MIP3 alpha stimulates the migration of Langerhans cells in models of human papillomavirus (HPV)-associated (pre)neoplastic epithelium.
Herman L; Hubert P; Caberg JH; Evrard B; Kedzia W; Boniver J; Delvenne P
Cancer Immunol Immunother; 2007 Jul; 56(7):1087-96. PubMed ID: 17146629
[TBL] [Abstract][Full Text] [Related]
11. [Role of immune alterations induced by papillomavirus in development of cervical cancer ].
Delvenne P
Bull Mem Acad R Med Belg; 2011; 166(1-2):28-33. PubMed ID: 22375488
[TBL] [Abstract][Full Text] [Related]
12. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
Hantz S; Alain S; Denis F
Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
[TBL] [Abstract][Full Text] [Related]
13. Colonization of in vitro-formed cervical human papillomavirus- associated (pre)neoplastic lesions with dendritic cells: role of granulocyte/macrophage colony-stimulating factor.
Hubert P; van den Brüle F; Giannini SL; Franzen-Detrooz E; Boniver J; Delvenne P
Am J Pathol; 1999 Mar; 154(3):775-84. PubMed ID: 10079255
[TBL] [Abstract][Full Text] [Related]
14. A review of cross-protection against oncogenic HPV by an HPV-16/18 AS04-adjuvanted cervical cancer vaccine: importance of virological and clinical endpoints and implications for mass vaccination in cervical cancer prevention.
Jenkins D
Gynecol Oncol; 2008 Sep; 110(3 Suppl 1):S18-25. PubMed ID: 18653221
[TBL] [Abstract][Full Text] [Related]
15. Silencing of E7 oncogene restores functional E-cadherin expression in human papillomavirus 16-transformed keratinocytes.
Caberg JH; Hubert PM; Begon DY; Herfs MF; Roncarati PJ; Boniver JJ; Delvenne PO
Carcinogenesis; 2008 Jul; 29(7):1441-7. PubMed ID: 18566017
[TBL] [Abstract][Full Text] [Related]
16. [Vaccination against cervical cancer and diseases caused by Human Papillomavirus].
Bornstein J; Tuma R; Zarfati D; Ophir E
Harefuah; 2007 Oct; 146(10):764-9, 814. PubMed ID: 17990391
[TBL] [Abstract][Full Text] [Related]
17. [Human papillomavirus and carcinoma of the cervix vaccines against the human papillomavirus-promise of an efficacious prevention].
Kohl I
Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):91-7. PubMed ID: 17051469
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of mucosal human papillomavirus infection and associated diseases.
Trottier H; Burchell AN
Public Health Genomics; 2009; 12(5-6):291-307. PubMed ID: 19684442
[TBL] [Abstract][Full Text] [Related]
19. Acquired immune response to oncogenic human papillomavirus associated with prophylactic cervical cancer vaccines.
Einstein MH
Cancer Immunol Immunother; 2008 Apr; 57(4):443-51. PubMed ID: 18157723
[TBL] [Abstract][Full Text] [Related]
20. [Immunity of the female genital tract mucosa and mechanisms of papillomavirus evasion].
Riethmuller D; Seilles E
J Gynecol Obstet Biol Reprod (Paris); 2000 Dec; 29(8):729-740. PubMed ID: 11139708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
